First Needle-free Treatment For Severe Hypoglycemia Gets FDA Nod

Until yesterday, the treatment of severe hypoglycemia was a glucagon injection that involves a clunky and complicated system. Today, with FDA approving the glucagon nasal powder Baqsimi from Eli Lilly (LLY), patients with severe hypoglycemia can breathe a little easier.

from RTT - Biotech https://ift.tt/2Za46Jm
via IFTTT